Stock Analysts

Harris Corp. Looks Promising

Continuous and valuable contract wins in the past have contributed to the steady upward spiraling in the share price of Harris Corporation ( HRS ), and have finally enabled this leading supplier of communications equipment and services to attain an all-time high of $79.32 on May 27, 2014. The stock price has surged 50% in the past one year mainly due to improved foreign defense expenditure, a strong tactical radio order and growth in the Government Communication segment. So far in the year, share price has increased 12.4%. […]

Downgrades

PARAMOUNT GOLD (PZG) Downgraded by Zacks to UNDERPERFORM

Zacks Investment Research downgraded shares of PARAMOUNT GOLD (PZG) from NEUTRAL to UNDERPERFORM on May 29, 2014, with a target price of $0.90. Paramount Gold and Silver Corp. engages in the acquisition, exploration, and development of gold, silver, and precious metal properties primarily in Mexico. […]

Downgrades

CRACKER BARREL (CBRL) Downgraded by Zacks to UNDERPERFORM

Zacks Investment Research downgraded shares of CRACKER BARREL (CBRL) from NEUTRAL to UNDERPERFORM on May 29, 2014, with a target price of $99.10. Cracker Barrel Old Country Store, Inc., formerly CBRL Group, Inc., is principally engaged in the operation and development of the Cracker Barrel Old Country Store restaurant and retail concept. The format of Cracker Barrel stores consists of a rustic, old country-store design with a separate retail area offering a variety of decorative and functional items featuring rocking chairs, holiday and seasonal gifts and toys, apparel, cookware and foods, including various old fashioned candies and jellies […]

Downgrades

GRAMERCY PROPRT (GPT) Downgraded by Zacks to NEUTRAL

Zacks Investment Research downgraded shares of GRAMERCY PROPRT (GPT) from N/A to NEUTRAL on May 29, 2014, with a target price of $6.10. Gramercy Property Trust Inc. operates as a commercial real estate investment and asset management company organized as a real estate investment trust. […]

Upgrades

PRGX GLOBAL INC (PRGX) Upgraded by Zacks to NEUTRAL

Zacks Investment Research upgraded shares of PRGX GLOBAL INC (PRGX) from UNDERPERFORM to NEUTRAL on May 29, 2014, with a target price of $6.50. PRGX Global, Inc., formerly PRG-Schultz International, Inc., provides audit, analytics, and advisory services in order to improve client financial performance. […]

Upgrades

AVIV REIT INC (AVIV) Upgraded by Zacks to OUTPERFORM

Zacks Investment Research upgraded shares of AVIV REIT INC (AVIV) from NEUTRAL to OUTPERFORM on May 29, 2014, with a target price of $30.20. Aviv REIT, Inc. is engaged in the ownership and triple-net leasing of post-acute and long-term care skilled nursing facilities primarily in the United States […]

FDA Approval

Oramed Pharmaceuticals Added to the Morgan Stanley Capital International (MSCI) MicroCap Index

Oramed Pharmaceuticals Added to the Morgan Stanley Capital International (MSCI) MicroCap Index PR Newswire JERUSALEM, May 29, 2014 JERUSALEM , May 29, 2014 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ( http://www.oramed.com ), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it has been added to the Morgan Stanley Capital International (MSCI) MicroCap Index, effective as of market close on May 30, 2014 . About the MSCI MicroCap Index MSCI is a leading provider of investment decision support tools to over 6,000 clients worldwide, ranging from pension plans to boutique hedge funds. […]

Stock Analysts

Intercept’s Obeticholic Acid Gets Fast Track Status

Shares of Intercept Pharmaceuticals ( ICPT ) have been on a rollercoaster ride this year due to mixed updates on the company’s lead pipeline candidate, obeticholic acid (OCA). Shares of the company were hammered a week ago after a report from The Street disclosed that the company had information about the occurrence of abnormal cholesterol levels in its phase IIb study on OCA when it came out with a press release on Jan 9, 2014. The trial was sponsored and conducted by the National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK). […]

Stock Analysts

Valeant Ups Offer for Allergan

Valeant Pharmaceuticals International, Inc . ( VRX ) announced that it has increased its offer price to acquire Allergan ( AGN ) by 21%. Valeant had proposed in Apr 2014 that each Allergan share would be exchanged for $48.30 in cash and 0.83 shares of Valeant's common stock. […]

Stock Analysts

Tyco Slips to Sell

On May 29, Zacks Investment Research downgraded security and protection services provider Tyco International Ltd. ( TYC ) to a Zacks Rank #4 (Sell) from a Zacks Rank #3 (Hold), primarily due to downward estimate revisions. Despite the downtrend, the company still has the potential to drive the stock up […]

Stock Analysts

First Horizon to Expand Tennessee Network

First Tennessee Bank, the major subsidiary of First Horizon National Corporation ( FHN ), is set to further enhance its footprint in Tennessee by acquiring 13 branches and four remote ATMs in the state from Bank of America Corporation ( BAC ). The acquisition of the branches is expected to close later this year. According to the terms of the deal, First Tennessee will assume deposits worth $660 million, for a 3.32% premium […]

Stock Analysts

PPL Corporation Touches 52-Week High

On May 28, 2014, the shares of PPL Corporation ( PPL ) climbed to a 52-week high of $34.66. The share price finally closed at $34.64, up 0.9% from the previous day’s closing. We believe that the company’s strong liquidity position, efficient cash generation capacity, disciplined investment in various projects, strategic asset divestment and payment of dividends at regular intervals have boosted the share price […]

Stock Analysts

BioMarin’s Pipeline Advances

BioMarin Pharmaceutical ( BMRN ) made progress regarding its pipeline when it commenced dosing in a phase III study (INSPIRE) on its candidate BMN 701 for the treatment of patients suffering from Pompe disease. Pompe disease, a rare lysosomal storage deficiency, has two main forms: infantile onset and late onset. The single-arm, open-label, switchover study will evaluate patients affected by late onset Pompe disease (an inherited disorder). […]

Mergers & Acquisitions

Mahindra & Mahindra Credit Rating Upgraded to AAA

Mahindra & Mahindra Credit Rating Upgraded to AAA PR Newswire MUMBAI, India, May 29, 2014 MUMBAI, India , May 29, 2014 /PRNewswire/ — Mahindra & Mahindra (M&M) recently received a Credit Rating upgrade to AAA, the highest level by India Ratings & Research, the domestic arm of global ratings agency, Fitch. The firm assigned a Long Term Issuer rating of ‘Ind AAA’ with a stable outlook to M&M. This upgrade is the result of the company’s resilience to economic cycles over the past 18 years, its strong market position, meaningful diversification activities, effective product development strategies, and conservative financial policies […]